In the News January 8, 2019

Business Monitor Online | Mylan Launches Mesalamine Generic in US

Alston & Bird is noted for representing Mylan Pharmaceuticals Inc. in a drug patent dispute with Shire Development LLC.
Media Contact
Nicholas Clarke
Senior Communications Manager
Phone: 212.210.1222

This website uses cookies to improve functionality and performance. For more information, see our Privacy Statement. Additional details for California consumers can be found here.